Zhu X - Search Results

1

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.

Zhu X, Ying J, Wang F, Wang J, Yang H. Zhu X, et al. Breast Cancer Res Treat. 2014 Oct;147(3):551-5. doi: 10.1007/s10549-014-3136-y. Epub 2014 Sep 19. Breast Cancer Res Treat. 2014. PMID: 25234844

2

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker.

Guo L, Li W, Zhu X, Ling Y, Qiu T, Dong L, Fang Y, Yang H, Ying J. Guo L, et al. Among authors: zhu x. Springerplus. 2016 Jun 21;5(1):805. doi: 10.1186/s40064-016-2513-x. eCollection 2016. Springerplus. 2016. PMID: 27390646 Free PMC article.

3

PIK3CA mutations and downstream effector p-mTOR expression: implication for prognostic factors and therapeutic targets in triple negative breast cancer.

Wang J, Zhu X, Xu X, Guo L, Shen G, Liu X, Chang C, Wang B, Yang H, Wang M. Wang J, et al. Among authors: zhu x. Int J Clin Exp Pathol. 2017 Jul 1;10(7):7682-7691. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966614 Free PMC article.

4

The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer.

Zhu X, Zhao L, Lang J. Zhu X, et al. Int J Gynecol Cancer. 2018 Oct;28(8):1514-1519. doi: 10.1097/IGC.0000000000001334. Int J Gynecol Cancer. 2018. PMID: 30045136 Free PMC article.

5

MicroRNA Dysregulation and Steroid Hormone Receptor Expression in Uterine Tissues of Rats with Endometriosis during the Implantation Window.

Cai H, Zhu XX, Li ZF, Zhu YP, Lang JH. Cai H, et al. Chin Med J (Engl). 2018 Sep 20;131(18):2193-2204. doi: 10.4103/0366-6999.240808. Chin Med J (Engl). 2018. PMID: 30203794 Free PMC article.

6

Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.

Zhu X, Yang H, Lang J, Zhang Y. Zhu X, et al. Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:103-108. doi: 10.1016/j.ejogrb.2019.06.015. Epub 2019 Jun 13. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31242460

7

The significance and therapeutic potential of PD-1 and its ligands in ovarian cancer: A systematic review.

Zhu X, Lang J. Zhu X, et al. Gynecol Oncol. 2016 Jul;142(1):184-189. doi: 10.1016/j.ygyno.2016.04.002. Epub 2016 Apr 15. Gynecol Oncol. 2016. PMID: 27063803 Review.

8

Genetic alteration profiling of patients with resected squamous cell lung carcinomas.

Tao D, Han X, Zhang N, Lin D, Wu D, Zhu X, Song W, Shi Y. Tao D, et al. Among authors: zhu x. Oncotarget. 2016 Jun 14;7(24):36590-36601. doi: 10.18632/oncotarget.9096. Oncotarget. 2016. PMID: 27145277 Free PMC article.

9

Carboplatin and programmed death-ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model.

Zhu X, Xu J, Cai H, Lang J. Zhu X, et al. J Obstet Gynaecol Res. 2018 Feb;44(2):303-311. doi: 10.1111/jog.13521. Epub 2017 Nov 24. J Obstet Gynaecol Res. 2018. PMID: 29171115

10

Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer.

Zhu X, Lang J. Zhu X, et al. J Gynecol Oncol. 2017 Sep;28(5):e64. doi: 10.3802/jgo.2017.28.e64. Epub 2017 Jun 5. J Gynecol Oncol. 2017. PMID: 28657225 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,896 results

Search Page

Filters